MedDRA 10.1 Review. MedDRA Version 10.1 What s coming ahead? MedDRA Version Changes. General Remarks. Terminology Files: What you need to know
|
|
- Eugene White
- 5 years ago
- Views:
Transcription
1 MedDRA 10.1 Review MedDRA Version Changes General Remarks Terminology Files: What you need to know MedDRA Version 10.1 Specific Changes Version 10.1 Changes Overview Changes in a Nutshell Changes Highlights MedDRA Version 10.1 Terminology Frequency Distribution MedDRA Version 10.1 What s coming ahead?
2 MedDRA Changes - General Remarks There are two possible types of changes to MedDRA terminology: simple changes and complex changes. Simple changes are changes to the existing terminology that involve terms at the PT and LLT levels. There are two types of Simple changes: (1) changes introduced by subscribers request and (2) Maintenance changes (also referred to as Associate changes). Maintenance changes are generated as a by-product of other changes requested by subscribers, or changes introduced by the MedDRA Management Board to preserve consistency within the dictionary. Complex changes involve modifications to HLT, HLGT, and SOC terminology. Currently, the initial MedDRA terminology version release in one specific year (5.0, 6.0, 7.0, 8.0, 9.0) includes both simple and complex changes, and the subsequent release in the same year (5.1, 6.1, 7.1, 8.1, 9.1) represents a simple change of terminology. These changes are based on MedDRA subscribers terminology change requests and on MedDRA terminology maintenance needs identified by MedDRA s maintenance organization reviewers. Please note that as a consequence of implementing some of these changes (e.g. demoting a multiaxial PT, adding a new HLT, etc.) it may be necessary to break the multiaxial links, to re-link the replacement terms, and/or to enable additional terms to be included within a particular SOC. All these changes may require modifications to your existing MedDRA coding, guideline development, and data retrieval practices. Back to MedDRA 10.1 Review
3 Files Containing MedDRA Terminology, Documentation, and Terminology Changes Information Directory Folder File Name Description How to use it intguide.pdf MedDRA Introductory Guide is a language specific document that describes characteristics of MedDRA including rules, conventions, and terminology hierarchy smqintguide.pdf whatsnew.pdf changereqinfo.pdf subpot.pdf phonecard.pdf!!readme.txt SMQ Introductory Guide is a document that describes SMQs basic concepts The "What's New" document provides a summary of all corresponding MedDRA version changes, modifications to terminology conventions, and information on other MedDRA-related activities MedDRA ASCII Files Documentation contains MedDRA files' description and fields definitions. In addition, it contains all the information required to create MedDRA relational MedDRA Consecutive File Documentation contains consecutive files' description and fields definitions. Change Request Information document provides all information regarding terminology change requests Subscriber Portfolio document contains details about your MedDRA subscription MedDRA MSSO Phone System provides information on how to access the MSSO by phone Readme document contains a list of all documents included in each new MedDRA version release. any reader that supports *.txt files
4 llt.asc Lower Level Term file. Contains ALL LLT in the hierarchy including noncurrent terms Refer to PDF document ascii.pdf for a complete description of this file's content and how to format it to create a table in a relational database pt.asc Prefer Term file. Contains all PT in the hierarchy. hlt.asc High Level Term file. Contains all HLT in the hierarchy. hlgt.asc High Level Group Term file. Contains all HLGT in the hierarchy. soc.asc System Organ Class file. Contains all 26 SOCs in the hierarchy. mdhier.asc MedDRA Hierarchy file. Contains the MedDRA hierarchy excluding LLTs. hltpt.asc PT & HLT codes file. Contains all PT-HLT associations. (most recent version hlgthlt.asc HLT & HLGT codes file.contains all HLT-HLGT associations.
5 sochlgt.asc HLGT & SOC codes file. Contains all HLGT-SOC associations. spec.asc Special Search Categories (SSC) file. Contains a list of all Special Search Categories. specpt.asc Special Search Categories & PT file. Contains a list of all Special Search Categories (SSC) and the PTs included in each. SMQList.asc Standardised MedDRA Query (SMQ) list file. Contains a complete list of all production (means available for use) SMQs. SMQContent.asc Standardised MedDRA Query (SMQ) content file. Contains all production SMQs and their respective subordinate terms. intlord.asc International System Organ Class order file. Contains the serial code for international System Organ Class sort order (based on relative importance of each SOC) llt.seq Lower Level Term sequential file. Contains all LLT changes since previous version. pt.seq Prefer Term file. Contains all PT changes since previous version.
6 hlt.seq High Level Term file. Contains all HLT changes since previous version. hlgt.seq High Level Group Term file. Contains all HLGT changes since previous version. soc.seq System Organ Class file. Contains all SOCs changes since previous version. mdhier.seq MedDRA Hierarchy file. Contains the MedDRA hierarchy changes since previous version. hltpt.seq PT & HLT codes file. Contains all PT-HLT changes since previous version. hlgthlt.seq HLT & HLGT codes file. Contains all HLT-HLGT changes since previous version. (most recent version sochlgt.seq HLGT & SOC codes file.contains all HLGT-SOC associations. spec.seq Special Search Categories (SSC) file. Contains a list of all Special Search Categories changes since previous version. specpt.seq Special Search Categories & PT file. Contains a list of all Special Search Categories (SSC) and the PTs changes since previous version.
7 intlord.seq International System Organ Class order file. Contains all changes to the serial code for international System Organ Class sort order (based on relative importance of each SOC) MedDRA MSSO Downloads Page: om/translations/download s.htm MedDRAVersionReports.xls MedDRA Verison Report file. Contains all MedDRA terminology changes since previous version release in a spreadsheet format. Microsoft Excel format. Very useful file for MedDRA version upgrade reviews. MedDRA MSSO Downloads Page: om/translations/download s.htm DetailedWhatsNewReport.pdf Detailed What's New Report file. Contains all version changes in full detail. Very useful file for MedDRA version upgrade reviews. Back to MedDRA 10.1 Review
8 MedDRA 10.1 Changes: Overview MedDRA Terminology Version 10.1 released in September 1, 2007 contains only simple changes. Following is a summary of the changes and several examples. To view a complete list of all terminology changes in version 10.1 go to: Version Report - (subscriber login required). Back to MedDRA 10.1 Review
9 Changes In a Nutshell Globalization of MedDRA - Addition of peculiar terms requested by nonnative English speakers Drug Abuse and Dependence terms mapping disconnect EMA - Volume 9A reporting compliance issues New SMQs Back to MedDRA 10.1 Review Changes Highlights Featured PT Changes New PTs Promoted LLTs Featured LLT Changes New LLTs Demoted PTs Currency changes Back to MedDRA 10.1 Review MedDRA Version 10.1 What s coming ahead? Back to MedDRA 10.1 Review
10 Changes In a Nutshell Globalization of MedDRA - Addition of peculiar terms requested by non-native English speakers MedDRA is used by investigators all over the world. This version includes peculiar terms not so frequently used in English speaking countries but which are commonly used in certain cultures. For example, the English term Paludism referring to malaria, is frequently used as such in Spanish speaking countries ( Paludismo ). Back Drug Abuse and Dependence terms mapping disconnect The location in the MedDRA hierarchy of Drug Abuse and Dependence has been a source of confusion and a stumbling block in the process of data search, retrieval, and analysis. In earlier versions of MedDRA Abuse terms existed under SOC Social circumstances while dependence terms were located under SOC Psychiatric disorders. Depending on the adverse event verbatim reports were mapped to one of these two SOCs which created some challenges for data users. However, if the term refers to a person, Drug abuser then the mapping goes into SOC Social circumstances. In summary, MedDRA version 10.1 SOC Psychiatric disorders, HLT Substance-related disorders include the following PTs: PT Name PT Alcohol abuse PT Alcohol problem PT Alcohol withdrawal syndrome PT Alcoholic hangover PT Alcoholism PT Dependence PT Dopamine dysregulation syndrome PT Drug abuse PT Drug dependence PT Drug dependence, antepartum PT Drug dependence, postpartum PT Drug withdrawal syndrome PT Drug withdrawal syndrome neonatal PT Intentional drug misuse PT Intentional overdose PT Multiple drug overdose intentional PT Neonatal complications of substance abuse PT Nicotine dependence PT Polysubstance dependence PT Substance abuse PT Tobacco abuse PT Tobacco withdrawal symptoms PT Withdrawal syndrome
11 Back European Union - Volume 9A reporting compliance issues In support of the European Union reporting requirements, version 10.1 includes the following terms: LLTName PTName HLTName HLGTName SOCName Transmission of an infectious agent via a Infectious Ancillary infectious Infections and medicinal product transmissions topics infestations Transmission of an infectious agent via a medicinal product Suspected transmission of an infectious agent via a medicinal product Transmission of an infectious agent via a medicinal product Infectious transmissions Ancillary infectious topics Infections and infestations Back New SMQs 1. Accidents and injuries (SMQ) 2. Acute central respiratory depression (SMQ) 3. Biliary disorders (SMQ) 4. Drug abuse, dependence and withdrawal (SMQ) 5. Extravasation events (injections, infusions and implants) (SMQ) 6. Gastrointestinal nonspecific inflammation and dysfunctional (SMQ) 7. Gastrointestinal perforation, ulceration, haemorrhage or obstruction (SMQ) 8. Guillain-Barre syndrome (SMQ) 9. Hostility/aggression (SMQ) 10. Hyponatraemia/SIADH (SMQ) 11. Noninfectious encephalitis (SMQ) 12. Noninfectious encephalopathy/delirium (SMQ) 13. Noninfectious meningitis (SMQ) 14. Oropharyngeal disorders (SMQ) 15. Psychosis and psychotic disorders (SMQ) 16. Pulmonary hypertension (SMQ) 17. Thrombophlebitis (SMQ) Torsade de pointes/qt prolongation (SMQ) was promoted to a free standing SMQ. Back to Changes in a Nutshell
12 Changes Highlights Featured PT Changes New PTs new PTs. Following are some examples. PT HLT HLGT SOC Cardiac valve disorders Heart valve incompetence Cardiac valve disorders Cardiac disorders Dysmyelination Abdominal wall haematoma Oral mucosal erythema Gingival erythema Bloody peritoneal effluent Oral disorder Gastrointestinal sounds abnormal Apparent death No adverse drug reaction No adverse event No adverse reaction Adverse reaction Disease complication Puncture site induration Metabolic and nutritional Lysosomal storage disorders disorders congenital Abdominal wall Abdominal hernias and other abdominal wall Congenital, familial and genetic disorders Gastrointestinal disorders Oral soft tissue signs and symptoms Oral soft tissue Gastrointestinal disorders Dental and gingival Gingival disorders Gastrointestinal disorders Peritoneal and retroperitoneal haemorrhages Peritoneal and retroperitoneal Gastrointestinal disorders Oral soft tissue disorders Oral soft tissue Gastrointestinal disorders Abdominal findings abnormal General signs and symptoms Adverse effect absent Adverse effect absent Adverse effect absent Therapeutic and nontherapeutic responses General signs and symptoms Administration site reactions Gastrointestinal signs and symptoms General system disorders General system disorders General system disorders General system disorders Therapeutic and nontherapeutic effects (excl toxicity) General system disorders Administration site reactions Gastrointestinal disorders General disorders and administration site General disorders and administration site General disorders and administration site General disorders and administration site General disorders and administration site General disorders and administration site General disorders and administration site General disorders and administration site Mucosal pigmentation Mucosal findings abnormal General system disorders Lower respiratory tract and Infections - pathogen Infections and Pleural infection bacterial lung infections unspecified infestations Sepsis, bacteraemia, viraemia and fungaemia Infections - pathogen Infections and Endotoxaemia unspecified infestations Rotavirus infection Rotaviral infections Viral infectious disorders Infections and
13 infestations Perihepatic abscess Abdominal and gastrointestinal infections Infections - pathogen unspecified Infections and infestations Quality of life decreased Investigations Investigations, imaging and histopathology procedures Investigations Type 2 diabetes mellitus Diabetes mellitus (incl subtypes) Glucose metabolism disorders (incl diabetes mellitus) Metabolism and nutrition disorders Type 1 diabetes mellitus Diabetes mellitus (incl subtypes) Glucose metabolism disorders (incl diabetes mellitus) Metabolism and nutrition disorders Pregnancy on contraceptive Unintended pregnancies Umbilical granuloma Sleep-related eating disorder Parasomnias Umbilical cord complications Pregnancy, labour, delivery and postpartum Neonatal and perinatal Sleep disorders and disturbances Pregnancy, puerperium and perinatal Pregnancy, puerperium and perinatal Psychiatric disorders Psychiatric and behavioural Psychiatric decompensation Psychiatric symptoms symptoms Sleep disorders and Confusional arousal Parasomnias disturbances Disturbances in initiating and Sleep disorders and Hyposomnia maintaining sleep disturbances Pharyngeal disorder Pharyngeal disorders (excl infections and neoplasms) Upper respiratory tract disorders (excl infections) Psychiatric disorders Psychiatric disorders Psychiatric disorders Respiratory, thoracic and mediastinal disorders Prescription form tampering Criminal activity Legal issues Social circumstances Antiretroviral therapy Astringent therapy Antiinfective therapies Therapeutic procedures Therapeutic procedures and supportive care Therapeutic procedures and supportive care Surgical and medical procedures Surgical and medical procedures Back
14 Featured LLT Changes New LLTs 458 new LLTs. Demoted PTs 95 PT were demoted to LLT level in version Currency changes the following 13 LLTs currency changed in version 10.1 LLT Version 10.1 Currency Ischialgia Current Laryngotracheobronchitis Current Pregnancy disorder Current Raised liver enzymes Current Reaction nonspecific Current Acute glomerulonephritis with lesion of rapidly progressive glomerulonephritis Non-current Elevated venous pressure during dialysis Non-current Glomerulonephritis rapidly progressive chronic Non-current Haemorrhage ant chamber eye Non-current Hemorrhage ant chamber eye Non-current Injection site redness mass Non-current Laryngotracheo bronchitis Non-current Na Non-current Back Back to MedDRA Changes Highlights
15 MedDRA Version 11.0 What s Coming Ahead? MedDRA terminology next release, version 11.0, is March Back to MedDRA Changes Highlights or Back to MedDRA 10.1 Review
16 MedDRA Version 10.1 Terminology Frequency Distribution by MedDRA Version Level Version 7.0 Version 7.1 Version 8.0 Version 8.1 Version 9.0 Version 9.1 Version 10.0 Version 10.1 SOC HLGT HLT 1,681 1,681 1,683 1,683 1,682 1,682 1,682 1,682 PT 16,449 16,559 16,751 16,976 17,320 17,505 17,719 17,867 LLT Current LLT's Non-current LLT's 61,204 52,253 8,951 61,704 52,740 8,964 62,348 53,370 8,978 62,950 53,967 8,983 63,817 54,834 8,983 64,620 55,621 8,999 65, ,125 9,022 65, ,580 9,025 Total 79,692 80,302 81,140 81,967 83,177 84, ,906 85,536 Back to MedDRA 10.1 Review
What s New MedDRA Version 13.1
What s New MedDRA Version 13.1 Acknowledgements ACKNOWLEDGEMENTS MedDRA is a registered trademark of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). Adobe is a registered
More informationWhat s New MedDRA Version March
C What s New MedDRA Version 21.0 Acknowledgements ACKNOWLEDGEMENTS MedDRA trademark is registered by IFPMA on behalf of ICH. Disclaimer and Copyright Notice This document is protected by copyright and
More informationWhat s New MedDRA Version March
c What s New MedDRA Version 20.0 Acknowledgements ACKNOWLEDGEMENTS MedDRA trademark is owned by IFPMA on behalf of ICH. Disclaimer and Copyright Notice This document is protected by copyright and may be
More informationWhat s New MedDRA Version 15.1
What s New MedDRA Version 15.1 Acknowledgements ACKNOWLEDGEMENTS MedDRA trademark is owned by IFPMA on behalf of ICH. Disclaimer and Copyright Notice This document is protected by copyright and may be
More informationWhat s New MedDRA Version 18.0
What s New MedDRA Version 18.0 Acknowledgements ACKNOWLEDGEMENTS MedDRA trademark is owned by IFPMA on behalf of ICH. Disclaimer and Copyright Notice This document is protected by copyright and may be
More informationMedDRA 10.0 Review. Terminology Files: What you need to know. MedDRA Version 10.0 Terminology Frequency Distribution
MedDRA 10.0 Review MedDRA Version Changes General Remarks Terminology Files: What you need to know MedDRA Version 10.0 Specific Changes Version 10.0 Changes Overview Changes in a Nutshell Changes Highlights
More informationWhat s New MedDRA Version MSSO-DI March 2016
c What s New MedDRA Version 19.0 Acknowledgements ACKNOWLEDGEMENTS MedDRA trademark is owned by IFPMA on behalf of ICH. Disclaimer and Copyright Notice This document is protected by copyright and may be
More informationWhat s New MedDRA Version 14.0
What s New MedDRA Version 14.0 Acknowledgements ACKNOWLEDGEMENTS MedDRA is a registered trademark of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). Adobe is a registered
More informationMedDRA 14.0 Review MedDRA Version Changes General Remarks MedDRA Version 14.0 Specific Changes Version 14.0 Changes Overview Changes in a Nutshell
MedDRA 14.0 Review MedDRA Version Changes General Remarks MedDRA Version 14.0 Specific Changes Version 14.0 Changes Overview Changes in a Nutshell Changes Highlights MedDRA Version 14.0 Terminology Frequency
More informationMedDRA 13.0 Review. General Remarks. Version 13.0 Changes Overview. Changes in a Nutshell. Changes Highlights. MedDRA Version Changes
MedDRA 13.0 Review MedDRA Version Changes General Remarks MedDRA Version 13.0 Specific Changes Version 13.0 Changes Overview Changes in a Nutshell Changes Highlights MedDRA Version 13.0 Terminology Frequency
More informationMedDRA Basic Concept
MedDRA Basic Concept Pansie Zhang MSD R&D (China) Co., Ltd 23Apr2015 Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not
More informationMedDRA Overview A Standardized Terminology
MedDRA Overview A Standardized Terminology Patrick Revelle Director, MedDRA MSSO 6 May 2010 MedDRA is a registered trademark of the International Federation of Pharmaceutical Manufacturers and Associations
More informationOverview of the MedDRA Data Retrieval and Presentation: Points to Consider Document including Standardised MedDRA Queries (SMQs)
Overview of the MedDRA Data Retrieval and Presentation: Points to Consider Document including Standardised MedDRA Queries (SMQs) Judy Harrison Chief Medical Officer MedDRA MSSO 22 October 2013 MedDRA Data
More informationMedDRA DATA RETRIEVAL AND PRESENTATION: POINTS TO CONSIDER
MedDRA DATA RETRIEVAL AND PRESENTATION: POINTS TO CONSIDER ICH-Endorsed Guide for MedDRA Users on Data Output Release 3.14 Based on MedDRA Version 20.1 1 September 2017 Disclaimer and Copyright Notice
More informationMedDRA DATA RETRIEVAL AND PRESENTATION: POINTS TO CONSIDER
MedDRA DATA RETRIEVAL AND PRESENTATION: POINTS TO CONSIDER ICH-Endorsed Guide for MedDRA Users on Data Output Release 3.6 Based on MedDRA Version 16.1 1 October 2013 Disclaimer and Copyright Notice This
More informationData Analysis and Query Building with MedDRA
Data Analysis and Query Building with MedDRA MedDRA was developed under the auspices of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The
More informationProposed MedDRA Version 17.0 Complex Changes (July 2013)
Proposed MedDRA Version 17.0 Complex Changes (July 2013) MedDRA User Submitted Requests: 1. Add a new HLT Exserohilum infections to HLGT Fungal infectious disorders Submitter rationale: Adding this HLT
More informationPreview of New MedDRA Hierarchy for Medication Errors Coding and Retrieval Considerations
Preview of New MedDRA Hierarchy for Medication Errors Coding and Retrieval Considerations Judy Harrison, M.D. Chief Medical Officer MedDRA MSSO Information Day on Medication Errors 20 October 2016 London,
More informationMedDRA - International standard for coding safety information. The Golden Triangle
MedDRA - International standard for coding safety information International Pharmacovigilance Conference Moscow, Russia 10 October 2018 Anna Zhao-Wong, MD, PhD MedDRA MSSO The Golden Triangle (MedDRA)
More informationImplemented MedDRA Version 22.0 Complex Changes (October 2018)
Implemented MedDRA Version 22.0 Complex Changes (October 2018) MedDRA User Proposed Requests: 1. Move HLT Cardiac disorders NEC from HLGT Cardiac disorder signs and symptoms to new HLGT Cardiac disorders
More informationData Analysis and Query Building with MedDRA
Data Analysis and Query Building with MedDRA MedDRA was developed under the auspices of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The
More informationMedDRA DATA RETRIEVAL AND PRESENTATION: POINTS TO CONSIDER
MedDRA DATA RETRIEVAL AND PRESENTATION: POINTS TO CONSIDER Release draft Based on MedDRA version 7.1 ICH-Endorsed Guide for MedDRA Users on Data Output 18 November 2004 Copyright ICH Secretariat (c/o IFPMA)
More informationFarmakovijilans ve MedDRA Pharmacovigilance and MedDRA FARMAKOVİJİLANS ve FARMAKOVİJİLANS UYGULAMALARI EKİM Dr.
Farmakovijilans ve MedDRA Pharmacovigilance and MedDRA FARMAKOVİJİLANS ve FARMAKOVİJİLANS UYGULAMALARI 23-24 EKİM 2003 Dr. Tomás Moraleda Agenda 1. What is MedDRA? 2. Conditions before MedDRA 3. MedDRA
More informationSafety Data Analysis and Query Creation with MedDRA
Safety Data Analysis and Query Creation with MedDRA Anne Kehely & Eva Rump Eli Lilly/MSSO 24th Annual EuroMeeting 26-28 March 2012 Copenhagen, Denmark Insert your logo in this area then delete this text
More informationData retrieval using the new SMQ Medication Errors
Data retrieval using the new SMQ Medication Errors Christina Winter Medical Director Safety Evaluation and Risk Management, GSK Information Day on Medication Errors 20 October 2016 London, UK Disclaimer
More informationAdvanced MedDRA Coding
Advanced MedDRA Coding MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The activities
More informationMedDRA DATA RETRIEVAL AND PRESENTATION: POINTS TO CONSIDER
MedDRA DATA RETRIEVAL AND PRESENTATION: POINTS TO CONSIDER Release 1.4 Based on MedDRA Version 10.1 ICH-Endorsed Guide for MedDRA Users on Data Output 12 September 2007 Copyright ICH Secretariat (c/o IFPMA)
More informationMedDRA Term Selection: Latest activities of the Points to Consider Working Group
MedDRA Term Selection: Latest activities of the Points to Consider Working Group Patrick Revelle MedDRA MSSO 23 May 2013 Overview The new EU pharmacovigilance legislation broadened the definition of an
More informationCoding with MedDRA 3/6/2019
Coding with MedDRA MedDRA was developed under the auspices of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The activities of the MedDRA
More informationMedDRA: Safety Data Analysis and SMQs
MedDRA: Safety Data Analysis and SMQs MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
More informationA chapter by chapter look at the ICD-10-CM code set Coding Tip Sheet
Coding Tip Sheet Chapter 1 - Certain Infectious and Parasitic Diseases Terminology changes: The term Sepsis (ICD-10-CM) has replaced the term Septicemia (ICD-9-CM) Urosepsis is a nonspecific term and is
More informationEpisodes of Care Risk Adjustment
Episodes of Care Risk Adjustment Episode Types Wave 1 Asthma Acute Exacerbation Perinatal Total Joint Replacement Wave 2 Acute Percutaneous Coronary Intervention COPD Acute Exacerbation Non-acute Percutaneous
More informationUse of MedDRA in Special Situations
Use of MedDRA in Special Situations Patrick Revelle MedDRA MSSO 13 March 2012 Overview Existing terms in MedDRA for off-label use, abuse, misuse, overdose, and medication errors Current coding recommendations
More informationMedDRA: Safety Data Analysis and SMQs
MedDRA: Safety Data Analysis and SMQs MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
More informationIntroduction to MedDRA
Introduction to MedDRA MedDRA trademark is owned by IFPMA on behalf of ICH MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration
More informationIntroductory Guide MedDRA Version 15.0
Introductory Guide MedDRA Version 15.0 Acknowledgements Notice to Reader This Introductory Guide is written in English and is intended only for use with the English version of MedDRA. Additional Introductory
More informationMedDRA Safety Data Analysis and SMQs
MedDRA Safety Data Analysis and SMQs MedDRA: Safety Data Analysis and SMQs MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration
More informationIntroductory Guide MedDRA Version 18.1
Introductory Guide MedDRA Version 18.1 Notice to Reader Notice to Reader This Introductory Guide is written in English and is intended only for use with the English version of MedDRA. Additional Introductory
More informationIntroductory Guide MedDRA Version 14.0
Introductory Guide MedDRA Version 14.0 Notice to Reader Notice to Reader This Introductory Guide is written in English and is intended only for use with the English version of MedDRA. Additional Introductory
More informationProactivity Proposals
What is proactive MedDRA Maintenance? In part, proactive maintenance means the MSSO may make corrections or improvements to MedDRA that we identify without receiving specific change requests from users.
More informationBest practices in VeDDRA coding
Best practices in VeDDRA coding 27 November 2013 Presented by: Giles Davis Chair of PhVWP-V VeDDRA sub-group An agency of the European Union Veterinary Dictionary for Drug Related Affairs SOC = System
More informationWhat Medical Writers Need to Know About MedDRA
What Medical Writers Need to Know About MedDRA Expert Seminar Series Session 2 40 th EMWA Conference, Dublin 6 May 2015 Judy Harrison, M.D. Chief Medical Officer, MedDRA MSSO MedDRA was developed under
More informationWHO-ART. Magnus Wallberg. November 24 th 2009 Dar Es Salaam, Tanzania.
WHO-ART Magnus Wallberg November 24 th 2009 Dar Es Salaam, Tanzania magnus.wallberg@who-umc.org WHO-ART (WHO-Adverse Reaction Terminology) The need for a medical terminology dyspnoea? tinnitus ARDS fever
More informationPerspective: E2B transmission
Perspective: E2B transmission I2B(M) Information about the safety report itself A.1 Report identification A.2 Primary source of information A.3.1 Who sends the information A.3.2 Who receives it Case information
More informationCoding with MedDRA 4/22/2015
Coding with MedDRA MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The activities
More informationSelected tables standardised to Segi population
Selected tables standardised to Segi population LIST OF TABLES Table 4.2S: Selected causes of death, all-ages, 2000 2004 (Segi Standard) Table 5.3S: Public hospitalisations by major cause of admission
More informationCoding with MedDRA. MedDRA trademark is owned by IFPMA on behalf of ICH
Coding with MedDRA MedDRA trademark is owned by IFPMA on behalf of ICH MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration
More informationCoding with MedDRA. of the MedDRA Maintenance and Support Services Organization (MSSO) are overseen by an ICH MedDRA
Coding with MedDRA MedDRA trademark is owned by IFPMA on behalf of ICH MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration
More informationCoding with MedDRA 3/2/2017
Coding with MedDRA MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The activities
More informationMedDRA Coding and Versioning
MedDRA Coding and Versioning 4th ANNUAL INNOVATIONS IN CLINICAL DATA MANAGEMENT Alexandria, VA. 27-28 October 2016 Anna Zhao-Wong, MD, PhD Deputy Director of MedDRA MSSO anna.zhao-wong@meddra.org Agenda
More informationIntroductory Guide for Standardised MedDRA Queries (SMQs) Version 14.0
Introductory Guide for Standardised MedDRA Queries (SMQs) Version 14.0 Acknowledgements Acknowledgements MedDRA is a registered trademark of the International Federation of Pharmaceutical Manufacturers
More informationSynopsis Style Clinical Study Report SR EFC10139 Version number: 1 (electronic 2.0)
SYNOPSIS Title of the study: A randomized, double-blind, parallel-group, multicenter, multinational study to assess the long-term effect, over 1 year, of rimonabant 10 mg in comparison with rimonabant
More informationMedDRA TERM SELECTION: POINTS TO CONSIDER
MedDRA TERM SELECTION: POINTS TO CONSIDER ICH-Endorsed Guide for MedDRA Users Release 4.13 Based on MedDRA Version 20.0 1 March 2017 Disclaimer and Copyright Notice This document is protected by copyright
More informationSearch for studies: ClinicalTrials.gov Identifier: NCT
ClinicalTrials.gov A service of the U.S. National Institutes of Health Search for studies: Example. "Heart attack" AND "Los Angeles" Advanced Search Help Studies by Topic Glossary Find Studies About Clinical
More informationAtrial Fibrillation We support the proposed modifications for atrial fibrillation. November 8, 2018 VIA ELECTRONIC MAIL
November 8, 2018 VIA ELECTRONIC MAIL Donna Pickett, MPH, RHIA ICD-10 Coordination and Maintenance Committee National Center for Health Statistics 3311 Toledo Road Hyattsville, Maryland 20782 Dear Ms. Pickett:
More informationFrequently Asked Questions
Welcome to the European MedDRA Users Group Webinar on Update on Medication errors The session will be chaired by Ian Slack Liz Thomas from the MSSO will provide technical support Asking Questions Using
More informationCase Series Drug Analysis Print Name: Vaxigrip, Fluarix, Inflexal V og Influenzacvaccine 01Sep Oct2014
- 16Oct2014 Report Run Date: 20-Oct-2014 Data Lock Date: 16-Oct-2014 19:00:06 Earliest Reaction Date: 28-Oct-2009 MedDRA Version: MedDRA 17.0 Vaxigrip, Fluarix, Inflexal V og Influenzacvaccine : Alle cases
More informationSmartVA Analyze Outputs Interpretation Sheet
SmartVA Analyze Outputs Interpretation Sheet SmartVA-Analyze uses an algorithm called Tariff 2.0 to assign the cause of death based on the details of the verbal autopsy (VA) interview. The output from
More informationCase Series Drug Analysis Print Name: Isotretinoin
Report Run Date: 30-Dec-2013 Data Lock Date: 27-Dec-2013 23:09:23 Earliest Reaction Date: 12-Jun-1997 MedDRA Version: MedDRA 16.1 Isotretinoin: No description provided. Report Run Date: 30-Dec-2013, Page
More informationThe study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationMedDRA Coding Quality: How to Avoid Common Pitfalls
MedDRA Coding Quality: How to Avoid Common Pitfalls Patricia Mozzicato, MD Chief Medical Officer MedDRA MSSO Disclaimer The views and opinions expressed in the following PowerPoint slides are those of
More informationThe causes of misuse:
The Drug Misuse The causes of misuse: Availability of drugs. A vulnerable personality. Adverse social environment. Regular drug taking play a role. Determining misuse and dependence, it is unclear whether
More informationEmergency Medicine Scope of Practice
Emergency Medicine Scope of Practice All Physician Assistants working in Emergency Medicine will encounter a wide variety of non acute, urgent and emergent patient complaints and conditions. Given the
More informationMedDRA TERM SELECTION: POINTS TO CONSIDER
MedDRA TERM SELECTION: POINTS TO CONSIDER Release 3.10 Based on MedDRA Version 11.0 ICH-Endorsed Guide for MedDRA Users Application to Adverse Drug Reactions /Adverse Events & Medical and Social History
More informationEfficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis
A service of the U.S. National Institutes of Health Trial record 1 of 1 for: CZOL446H2409 Previous Study Return to List Next Study Efficacy Study of Zoledronic Acid and Combination Therapy in Women With
More informationClinical Pharmacology and Drug Therapy
Oxford Textbook of Clinical Pharmacology and Drug Therapy THIRD EDITION D. G. Grahame-Smith CBE, MBBS, PhD, FRCP Emeritus Professor of Clinical Pharmacology, University of Oxford and J.K. Aronson MBChB,
More informationMedDRA Coding/ AE Log Item 1 Refresher. ASPIRE Protocol Team Meeting February 10, 2013
MedDRA Coding/ AE Log Item 1 Refresher ASPIRE Protocol Team Meeting February 10, 2013 MedDRA Coding Overview MedDRA: standardized dictionary of medical terminology Results from ICH initiative to standardize
More informationMedDRA TERM SELECTION: POINTS TO CONSIDER
MedDRA TERM SELECTION: POINTS TO CONSIDER ICH-Endorsed Guide for MedDRA Users Release 4.8 Based on MedDRA Version 17.1 1 September 2014 Disclaimer and Copyright Notice This document is protected by copyright
More informationPHO: Metadata for Mortality from Avoidable Causes
Snapshots @ PHO: Metadata for Mortality from Avoidable Causes This indicator captures individuals under 75 years of age who have died with a condition considered as avoidable recorded as the primary cause
More informationIntroductory Guide for Standardised MedDRA Queries (SMQs) Version 18.1
Introductory Guide for Standardised MedDRA Queries (SMQs) Version 18.1 Acknowledgements Acknowledgements MedDRA trademark is owned by IFPMA on behalf of ICH. Disclaimer and Copyright Notice This document
More informationICD-10 Physician Education. General Surgery
ICD-10 Physician Education General Surgery 1 Training Objectives ICD-9 to ICD-10 Comparison Documentation Tips Additional Educational Opportunities Questions 2 ICD-9 to ICD-10 Comparison Code Structure
More informationCoding with MedDRA 1
Coding with Coding with MedDRA 1 4/3/2015 Coding with MedDRA MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals
More informationClinical Science Examination Content Outline
Clinical Science Examination Content Outline International Foundations of Medicine National Board of Medical Examiners Table of Contents Physician Tasks/Competencies... 2 Test Specifications... 2 Medical
More information0301 Anemia Others. Endocrine nutritional and metabolic disorders Others Vascular dementia and unspecified dementia
Certain infectious and parasitic diseases 0101 Intestinal infectious diseases 0102 Tuberculosis 0103 Infections with a predominantly sexual mode of transmission 0104 Viral infections characterized by skin
More informationIII. KNOWLEDGE BASE ON THE 65 CAUSES OF DEATH (EUROSTAT SHORT LIST)
III. KNOWLEDGE BASE ON THE 65 CAUSES OF DEATH (EUROSTAT SHORT LIST) This section of the report on the 'Knowledge base on the 65 causes of death' comprises two parts: a published studies database and an
More informationLeading Causes of Death, Tarrant County, 2008
Tarrant County Public Health Division of Epidemiology and Health Information Leading Causes of Death, Tarrant County, 00 Table 1. deaths by gender, Tarrant County, 00 Male,7. 70. Female,7 0.1 7. Total,7
More informationAttending Physician s Statement
( Form A A This form is used for claiming the social insurance benefit. This form should be completed and signed by the attending physician outpatient and One form for each month, one form for hospitalization
More informationSession 2. Data analysis based on overview of EudraVigilance data. Victoria Newbould, EMA, EU. Medication-errors workshop London, 20 October 2016
Session 2 Data analysis based on overview of EudraVigilance data Victoria Newbould, EMA, EU Medication-errors workshop London, 20 October 2016 An agency of the European Union Acknowledgement Steven Le
More informationAcute Respiratory Distress We support creation of a unique code for acute respiratory distress.
November 13, 2016 VIA ELECTRONIC MAIL Donna Pickett, MPH, RHIA ICD-10 Coordination and Maintenance Committee National Center for Health Statistics 3311 Toledo Road Hyattsville, Maryland 20782 Dear Ms.
More informationLeading Causes of Death, Tarrant County, 2007
Tarrant County Public Health Division of Epidemiology and Health Information Leading Causes of Death, Tarrant County, 007 Table 1. deaths by gender, Tarrant County, 007 Males,1 4. 70. Females,7 0. 741.
More informationOutcomes of Health Systems : Towards the development of indicators of amenable mortality
Outcomes of Health Systems : Towards the development of indicators of amenable mortality Work: Juan G. Gay Presentation: Valérie Paris OECD October 9, 2009 Objectives of the project Explore the potential
More informationLeading Causes of Death, Tarrant County, 2009
Tarrant County Public Health Division of Epidemiology and Health Information Leading Causes of Death, Tarrant County, 009 Table. deaths by gender, Tarrant County, 009 Male 5,5 9. 90. Female 5, 50. 70.
More informationOptum360 Learning: Detailed Instruction for Appropriate ICD-10-CM Coding
Optum360 Learning: Detailed Instruction for Appropriate Coding An educational guide to the structure, conventions, and guidelines of coding 2017 Contents Section 1: Introduction...1 Documentation...7 Documentation
More informationMedDRA TERM SELECTION: POINTS TO CONSIDER
MedDRA TERM SELECTION: POINTS TO CONSIDER ICH-Endorsed Guide for MedDRA Users Release 4.4 Based on MedDRA Version 15.1 1 October 2012 Disclaimer and Copyright Notice This document is protected by copyright
More informationDRG Code DRG Description FY18 Average Charge
DRG Code DRG Description FY18 Average Charge 3 ECMO OR TRACH W MV 96+ HRS OR PDX EXC FACE, MOUTH & NECK W MAJ O $ 665,511 4 TRACH W MV 96+ HRS OR PDX EXC FACE, MOUTH & NECK W/O MAJ O.R. $ 422,497 37 EXTRACRANIAL
More informationAPR-DRG Description Ave Charge
Abdominal Pain 16,500.25 2.8 6,000.09 Acute & Subacute Endocarditis 15,339.30 3.0 5,113.10 Acute Myocardial Infarction 17,687.46 2.6 6,802.87 Alcohol Abuse & Dependence 19,126.64 4.2 4,553.96 Alcoholic
More informationSupplementary Online Content
Supplementary Online Content Lee C-C, Lee M-tG, Chen Y-S. Risk of aortic dissection and aortic aneurysm in patients taking oral fluoroquinolone. JAMA Internal Medicine. Published online October 5, 2015.
More informationTN Bundled Payment Initiative: Overview of Episode Risk Adjustment
TN Bundled Payment Initiative: Overview of Episode Risk Adjustment United Healthcare, April 2014 The State of Tennessee has implemented an episode-based approach to reimburse providers for the care delivered
More informationTable of Contents. Course CME Credits. General Principles Topic CME Credit(s)
Table of Contents Course Course CME Credits Med-Challenger SPEX Comprehensive Review 266.0 CME Credits General Principles 21.0 CME Credit(s) Abdominal Pain 1.0 Acute Pelvic Pain in Women 1.0 Acute Vaginal
More informationChapter 10 Respiratory System J00-J99. Presented by: Jesicca Andrews
Chapter 10 Respiratory System J00-J99 Presented by: Jesicca Andrews 1 Respiratory System 2 Respiratory Infections A respiratory infection cannot be assumed from a laboratory report alone; physician concurrence
More informationAnnual High Claims Survey. Year Ending 31 December 2016
Annual High Claims Survey Year Ending 31 December 2016 Released July 2017 Summary The Private Healthcare Australia Annual High Claims Survey Report analyses the nature and magnitude of high claims met
More informationNAME: DATE: SCHOOL/ORGANISATION:
HEALTH AND FITNESS NAME: DATE: SCHOOL/ORGANISATION: INSTRUCTIONS 1. Make sure you read the bold text in boxes throughout the worksheet as they contain important information. These boxes contain instructions
More informationMayo Clinic Physician Assistant Board Review
PHARMACOLOGY CONTENT Mayo Clinic Physician Assistant Board Review Select presentations will contain pharmacology content as noted in the program. Identified presentations represent approximately 11.75
More informationCoding with Confidence
Coding with Confidence Hilary Vass (Global Clinical Dictionary Manager AstraZeneca UK Limited) Tomás Moraleda (Medical Officer MSSO) 25th Annual EuroMeeting 4-6 March 2013 RAI, Amsterdam Netherlands Disclaimer
More informationProduct Catalog. Pediatric Learning Solutions. Listing of all current products (as of May, 2013) offered by Children's Hospital Association.
Product Catalog Pediatric Learning Solutions Listing of all current products (as of May, 2013) offered by Children's Hospital Association. Acquired Heart Disease in Children WBT Acute Respiratory Distress
More informationTABLE I-1: RESIDENT INFANT DEATHS PER 1,000 LIVE BIRTHS, BY RACE AND ETHNICITY, FLORIDA AND UNITED STATES, CENSUS YEARS AND
TABLE I-1: RESIDENT INFANT DEATHS PER 1,000 LIVE BIRTHS, BY RACE AND ETHNICITY, FLORIDA AND UNITED STATES, CENSUS YEARS 1970-2000 AND 2004-2014 FLORIDA 1 UNITED STATES 1 YEAR WHITE2 BLACK2 HISPANIC3 WHITE2
More informationTerminologies for recording of ADR:s
Terminologies for recording of ADR:s 1 Adverse reaction terms? Dizziness SOB. feeling hot.? dyspnoea lightheadedness.? breath shortness. evidence of VEBS on 2 ECG Concepts Terminology collection of accepted
More informationCoding with MedDRA. Course Overview
Coding with MedDRA MedDRA is a registered trademark of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Course Overview MedDRA background MedDRA s structure, scope,
More informationTENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 8 Episodes
TENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 8 Episodes Acute Seizure, Syncope, Acute Gastroenteritis, Pediatric Pneumonia, Bronchiolitis, Colposcopy, Hysterectomy,
More informationUpdate overview 2018 of reports on direct oral anticoagulants (DOACs) and the antidote idarucizumab
Update overview 2018 of reports on direct oral anticoagulants (DOACs) and the antidote idarucizumab Introduction Lareb previously published yearly overviews of reports (most recently in 2017) in consultation
More information